Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections

OBJECTIVE: To investigate how to use polymyxin B rationally in order to produce the best efficacy and safety in patients with carbapenem-resistant gram-negative organisms (CRO) infection. METHODS: The clinical characteristics and microbiological results of 181 patients caused by CRO infection treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, G. L., Jiang, R. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488323/
https://www.ncbi.nlm.nih.gov/pubmed/34607561
http://dx.doi.org/10.1186/s12879-021-06719-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488323/
https://www.ncbi.nlm.nih.gov/pubmed/34607561
http://dx.doi.org/10.1186/s12879-021-06719-y

Ejemplares similares